Table 3.
Subgroup analysis of PTB incidence and prevalence in T2DM.
| Subgroups | N | Effect size [95% CI] | I2 | p Value of between-subgroup heterogeneity |
|---|---|---|---|---|
| Incidence (per 100,000 person-years) | ||||
| Region | <0.01 | |||
| Aisa | 15 | 187.20 (147.76, 237.17) | 99.3% | |
| Europe | 3 | 20.24 (14.64, 27.99) | 85.7% | |
| TB-burden | 0.01 | |||
| High | 12 | 172.04 (122.98, 240.68) | 99.3% | |
| Low | 6 | 73.75 (40.92, 132.91) | 99.8% | |
| Criteria of PTB | <0.01 | |||
| ICD-9 | 8 | 203.30 (153.90, 268.55) | 98.4% | |
| ICD-10 | 6 | 73.75 (40.92, 132.91) | 99.8% | |
| Guidelines for the implementation of China’s TB control Program (2008) | 2 | 85.37 (30.25, 240.87) | 95.8% | |
| Guidelines for the implementation of China’s TB control Program (2002) | 1 | 119.85 (111.76, 128.53) | – | |
| By reviewing medical or public health records | 1 | 270.00 (218.63, 333.45) | – | |
| Ending year of data collection | <0.01 | |||
| ≤2011 | 10 | 219.81 (176.15, 274.28) | 99.2% | |
| >2011 | 8 | 66.18 (28.73, 152.47) | 99.5% | |
| Prevalence (per 100,000) | ||||
| Region | <0.01 | |||
| Aisa | 19 | 594.19 (431.86–817.54) | 99.6% | |
| Africa | 3 | 617.43 (287.07, 1327.96) | 83.5% | |
| Europe | 2 | 105.01 (72.55, 151.98) | 90.6% | |
| TB-burden | <0.01 | |||
| High | 17 | 692.15 (468.75, 1022.04) | 99.4% | |
| Low | 7 | 250.73 (180.22, 348.84) | 99.2% | |
| Study design | 0.89 | |||
| Cohort | 14 | 503.19 (339.72, 745.30) | 99.8% | |
| Cross-sectional | 10 | 524.95 (324.17, 850.07) | 90.4% | |
PTB: pulmonary tuberculosis; TB: tuberculosis; N: number, CI: confidence intervals.